Natalizumab treated multiple sclerosis patients had greatly increased the formation of TNF and significantly decreased expression of IL10 in circulating CD4+ and CD8+ T cells which does not correlate between Expanded Disability Status Scale (EDSS) or the disease. Expanded Disability Status Scale (EDSS) is a method by which disability is determined in multiple sclerosis. Also, there were no contrast in the CD4+ T cell proliferation or expression of cytokine in untreated and multiple sclerosis patients treated with natalizumab and natalizumab had no serious effect on the part of proliferating CD4+ T cells or a formation of IL-17A and IFN-c in MBP-reactive CD3+ CD8 T cells. CD4+ and CD8+ T cells from patients treated with natalizumab shows levels of messenger RNA encoding TNF-a transcript. Effector T cells also have a high capacity in the production of pro-inflammatory cytokines and may result to a better pool of pro inflammatory
Natalizumab treated multiple sclerosis patients had greatly increased the formation of TNF and significantly decreased expression of IL10 in circulating CD4+ and CD8+ T cells which does not correlate between Expanded Disability Status Scale (EDSS) or the disease. Expanded Disability Status Scale (EDSS) is a method by which disability is determined in multiple sclerosis. Also, there were no contrast in the CD4+ T cell proliferation or expression of cytokine in untreated and multiple sclerosis patients treated with natalizumab and natalizumab had no serious effect on the part of proliferating CD4+ T cells or a formation of IL-17A and IFN-c in MBP-reactive CD3+ CD8 T cells. CD4+ and CD8+ T cells from patients treated with natalizumab shows levels of messenger RNA encoding TNF-a transcript. Effector T cells also have a high capacity in the production of pro-inflammatory cytokines and may result to a better pool of pro inflammatory